atropine has been researched along with Bladder, Overactive in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chakrabarty, B; Fry, CH; Ikeda, Y; Jabr, RI; Kanai, AJ; McCarthy, CJ; Skennerton, D | 1 |
| Mizutani, H; Sakakibara, F; Sasaki, E | 1 |
| Kulieva, EM; Paduraru, ON; Philyppov, IB; Shuba, YM; Shuba, YY; Vladimirova, IA | 1 |
| Nanri, M; Sakakibara, F; Sasaki, E; Takahama, K | 1 |
| Dasgupta, J; Elliott, RA; Tincello, DG | 1 |
| Kiniwa, M; Nanri, M; Sakakibara, F | 1 |
| Chancellor, MB; Hirao, Y; Kita, M; Matsumoto, Y; Miyazato, M; Yokoyama, H; Yoshimura, N | 1 |
| Brading, AF; Fabiyi, AC | 1 |
| Barton, R; Brooks, R; Fader, M; Glickman, S; Haggar, V; Malone-Lee, J | 1 |
| Hatanaka, T; Miyata, K; Noguchi, Y; Ohtake, A; Okutsu, H; Saitoh, C; Sasamata, M; Sato, S; Suzuki, M; Ukai, M; Yuyama, H | 1 |
| Akino, H; Aoki, Y; Ito, H; Miwa, Y; Oyama, N; Yokoyama, O | 1 |
| Akino, H; Aoki, Y; Ito, H; Matsuta, Y; Miwa, Y; Nakai, M; Oyama, N; Tanase, K; Yokoyama, O; Yusup, A | 1 |
1 trial(s) available for atropine and Bladder, Overactive
| Article | Year |
|---|---|
Intravesical atropine compared to oral oxybutynin for neurogenic detrusor overactivity: a double-blind, randomized crossover trial.
Topics: Administration, Intravesical; Administration, Oral; Adult; Aged; Atropine; Cross-Over Studies; Double-Blind Method; Humans; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive | 2007 |
11 other study(ies) available for atropine and Bladder, Overactive
| Article | Year |
|---|---|
Characterisation of nerve-mediated ATP release from bladder detrusor muscle and its pathological implications.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Atropine; Electric Stimulation; Guinea Pigs; Humans; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; Receptors, Purinergic P2X1; Species Specificity; Urinary Bladder; Urinary Bladder, Overactive | 2019 |
TAS-303 Ameliorates Carbachol-Induced Detrusor Overactivity in Rats, Revealing Its Therapeutic Potential for Overactive Bladder.
Topics: Adrenergic beta-3 Receptor Antagonists; Animals; Atropine; Carbachol; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Muscle Contraction; Muscle, Smooth; Rats; Receptors, Muscarinic; Urinary Bladder; Urinary Bladder, Overactive | 2020 |
[Impact of diabetic complications on neuromuscular transmission in the smooth muscle of the bladder of rats with experimental diabetes].
Topics: Animals; Atropine; Cyclooxygenase 1; Cyclooxygenase 2; Cyclophosphamide; Cystitis; Diabetes Mellitus, Experimental; Electric Stimulation; Indomethacin; Membrane Proteins; Muscle Contraction; Muscle, Smooth; Neuromuscular Junction; Peptidoglycan; Prostaglandins; Rats; Staphylococcus aureus; Streptozocin; Synaptic Transmission; Urinary Bladder; Urinary Bladder, Overactive | 2015 |
Pharmacological Properties of Propiverine Contribute to Improving Lower Urinary Tract Dysfunctions in Rats with Spinal Cord Injuries.
Topics: Animals; Atropine; Benzilates; Capsaicin; Female; Muscarinic Antagonists; Rats; Spinal Cord Injuries; Urinary Bladder; Urinary Bladder, Overactive; Verapamil | 2016 |
Modification of rat detrusor muscle contraction by ascorbic acid and citric acid involving enhanced neurotransmitter release and Ca2+ influx.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Ascorbic Acid; Atropine; Calcium Signaling; Carbachol; Cholinergic Agonists; Citric Acid; Dose-Response Relationship, Drug; Electric Stimulation; Female; Food Preservatives; In Vitro Techniques; Muscarinic Antagonists; Muscle Contraction; Perfusion; Potassium; Presynaptic Terminals; Rats; Rats, Wistar; Time Factors; Urinary Bladder; Urinary Bladder, Overactive | 2009 |
Are antimuscarinic drugs effective against urinary frequency mediated by atropine-resistant contractions?
Topics: Animals; Atropine; Calcium Channel Blockers; Calcium Channels, L-Type; Disease Models, Animal; Female; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Rats; Rats, Sprague-Dawley; TRPV Cation Channels; Urinary Bladder; Urinary Bladder, Overactive; Urinary Incontinence; Urination | 2011 |
Role of M2 and M3 muscarinic acetylcholine receptor subtypes in activation of bladder afferent pathways in spinal cord injured rats.
Topics: Afferent Pathways; Animals; Atropine; Benzofurans; Diamines; Female; Mucous Membrane; Muscarinic Agonists; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Oxotremorine; Parasympatholytics; Pressure; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M2; Receptor, Muscarinic M3; RNA, Messenger; Spinal Cord Injuries; Thoracic Vertebrae; Urinary Bladder; Urinary Bladder, Overactive | 2012 |
The use of the isolated mouse whole bladder for investigating bladder overactivity.
Topics: Adenosine Triphosphate; Anesthetics, Local; Animals; Atropine; Bradykinin; Carbachol; Dose-Response Relationship, Drug; Electric Stimulation; Female; In Vitro Techniques; Mice; Muscarinic Agonists; Muscarinic Antagonists; Muscle, Smooth; Neurons; Receptors, Muscarinic; Tetrodotoxin; Urinary Bladder; Urinary Bladder, Overactive | 2006 |
Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents.
Topics: Animals; Atropine; Benzhydryl Compounds; Benzilates; Benzofurans; Binding, Competitive; Carbachol; CHO Cells; Cholinergic Agonists; Cresols; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Mandelic Acids; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; N-Methylscopolamine; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Muscarinic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Transfection; Urinary Bladder; Urinary Bladder, Overactive; Urination | 2007 |
Antimuscarinic drug inhibits detrusor overactivity induced by topical application of prostaglandin E2 to the urethra with a decrease in urethral pressure.
Topics: Administration, Intravesical; Administration, Topical; Adrenergic alpha-Antagonists; Animals; Atropine; Benzilates; Calcium Channel Blockers; Cholinergic Antagonists; Dinoprostone; Disease Models, Animal; Female; Injections, Intra-Arterial; Muscarinic Antagonists; Muscle Contraction; omega-Conotoxins; Oxytocics; Pressure; Rats; Rats, Sprague-Dawley; Sulfonamides; Tamsulosin; Treatment Outcome; Urethra; Urinary Bladder; Urinary Bladder, Overactive; Verapamil | 2007 |
Effects of antimuscarinics on voiding function after cerebral infarction in a rat model of overactive bladder.
Topics: Animals; Atropine; Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Female; Infarction, Middle Cerebral Artery; Injections, Intraventricular; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Phenylpropanolamine; Rats; Rats, Sprague-Dawley; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder, Overactive; Urinary Catheterization; Urination | 2007 |